2020 has been a year marked by uncertainty, challenge, and change. Yet those suffering from rare diseases had to deal with all 2020 put forth on top of the burdens of their conditions. As such, our mission at RareMed has …Read More →

This time of year evokes joy, a sense of thankfulness, and a desire to reflect on the year behind us. RareMed Solutions would like to take the opportunity to thank our patients for the role they play in our organization. …Read More →

In this season of gratitude, we extend our sincere thanks to our RareMed associates for their daily displays of hard work and dedication. Our associates have taken on the challenges of this year with optimism and determination, providing unwavering support …Read More →

From the beginning, RareMed has grown, accomplished, and thrived with the help and support of our exceptional partners. Aligned in our values and focus on patient success, RareMed’s partners entrust us with the health and wellbeing of their exceptional patients. …Read More →

Read the Official Press Release. Ernst & Young LLP (EY US) yesterday announced that Dr. Gordon J. Vanscoy, Chairman & CEO of both PANTHERx Rare and RareMed Solutions, was named an Entrepreneur Of The Year® 2020 National Award winner following …Read More →

RareMed Solutions is pleased to announce that we have been recognized as a 2020 Best Place Work Awardee by the Pittsburgh Business Times. At RareMed, we dedicate ourselves to the health of our patients and know that the best way …Read More →

Read the Official RareMed Solutions Press Release. RareMed Solutions announces that it has been selected by PTC Therapeutics, Inc. to provide non-commercial dispensing services for the drug EMFLAZA® (deflazacort). RareMed will be the exclusive free drug provider for EMFLAZA®, managing …Read More →

Smart Business Magazine has announced that Dr. Gordon J. Vanscoy, Chairman & CEO of RareMed & PANTHERx Rare, was selected as a 2020 Smart 50 Award honoree. Since 2014, the Pittsburgh Smart 50 Awards have recognized the top executives from …Read More →

Ernst & Young LLP (EY US) announced today that Dr. Gordon J. Vanscoy, Chairman & CEO of RareMed Solutions & PANTHERx Rare, was named a 2020 Entrepreneur of The Year® East Central Award winner. As a regional award winner, Dr. …Read More →

In their white paper, Meeting the Sophisticated Needs of Rare Disease Non-Commercial Pharmacy Management, RareMed Solutions explores the details of how non-commercial pharmacies play an enormous role in providing the proper therapies and programs to rare disease patients, while lessening …Read More →